If Meta rejects your aesthetic clinic's ad, save the actual decision and identify which part of the campaign it concerns before changing anything. The problem may involve the creative, destination, targeting or a separate account restriction. Replacing a treatment name repeatedly is not a reliable investigation and can remove useful information without resolving the issue.
Begin with one affected ad. Record its identifier, policy label, linked destination and current settings. Then compare the flagged material with the current official policy. If you believe the decision is wrong, prepare a factual review request through the route available in your account. Do not make a new account or conceal the service to work around enforcement.
Preserve the evidence before editing
Save the decision notice, the relevant policy link and the version of the ad that received the decision. Include the image or video, headline, text, form or destination and targeting settings. Keep this evidence in a practice-approved location without patient records or unnecessary personal information.
Note whether the restriction applies to an individual ad, an asset, an account or a data source. Those are different investigations. A notice about event sharing is not proof that a particular sentence is prohibited. An ad rejection does not establish that the whole business is banned from advertising.
Also record what changed just before the issue appeared. A new landing page, revised offer or different audience can matter as much as a headline edit. That history prevents the team from arguing about a version nobody can reproduce.
Use the policy label, not a social-media word list
Treat an online list of forbidden words as an unverified shortcut. An ad's meaning depends on context, not just individual terms. A phrase can imply something about the viewer without using an obvious medical word; another phrase can describe a service neutrally.
Meta's personal-attributes policy prohibits assertions or implications about specified personal attributes, including medical information. It does not impose a blanket ban on the words you and your. Review what the whole sentence implies.
For a practice owner, the useful question is: does this copy describe what we offer, or imply that we know something sensitive about the person seeing it? Have the appropriate practice and policy reviewers examine the actual wording. Replacing a pronoun does not automatically make an underlying claim acceptable.
Avoid writing an appeal that says competitors use this phrase. Another advertiser's visible ad is not evidence of your own campaign's compliance or of the review history behind that ad.
Check cosmetic-service claims against the current version
Consult Meta's Health and Wellness policy directly. Its current wording includes adult targeting for cosmetic procedures and restrictions on appearance-related and other claims. Do not rely on an older summary that treats all before-and-after imagery as automatically prohibited.
An allowed format is not proof that a specific image, claim or consent arrangement is appropriate. Have the practice's qualified reviewers check truthful context, permissions and any clinical statement. Avoid presenting a patient's individual outcome as a promise to the audience.
When a policy has changed, record the version you checked and the date. The investigation should explain what the current rule says and how the actual ad relates to it, not rely on a remembered interpretation from a previous campaign.
Inspect the destination as carefully as the ad
Open the final destination on mobile and desktop. Follow redirects and any booking or inquiry link. Confirm that the page still describes the advertised service, location and next step.
Look for inconsistent price claims, unsupported outcome language or a form that asks for information the public inquiry does not need. Check promotional pop-ups and embedded content as well as the headline. Do not assume that a neutral ad makes everything behind it suitable for the campaign.
Separate useful clarification from concealment. Explaining a consultation more accurately is a legitimate editorial improvement. Hiding the real offer behind an unrelated page to avoid review is not an acceptable troubleshooting strategy.
If the destination includes clinical claims or sensitive-data collection, route those questions to the appropriate qualified reviewers. This investigation log does not determine an individual clinic's legal obligations or approve its intake design.
Keep creative, audiences and measurement separate
Use three tracks in the investigation: what the ad communicates, who the campaign is configured to reach and what information the website or platform receives. A change in one track should not be presented as solving all three.
For example, a clinic might have neutral service copy but an unresolved question about event sharing. A different clinic might have an account-level issue while the team keeps editing individual images. The right action depends on the notice and configuration, not the fact that both situations involve aesthetic services.
Do not change event names, domains or account structures to hide a sensitive workflow. Record what is collected and who receives it. Resolve the actual data question before using a reporting workaround that merely makes the warning less visible.
Copy this ad-rejection investigation log
Create one log per decision, not one general note called Meta problem.
- Decision scope: ad, asset, account, destination or data source, as actually stated.
- Affected identifier: the exact ad or other object, with the notice date.
- Policy label and link: retain the platform's wording and the official page consulted.
- Campaign version: creative, copy, offer, destination and relevant settings at the time.
- Observed mismatch: the specific element that appears to conflict, or why the decision may be mistaken.
- Evidence limits: anything not yet inspected or not visible in the account.
- Reviewer: the role responsible for policy, clinical or privacy questions, as relevant.
- Proposed action: correct an identified issue, seek clarification or request review.
- Change record: exactly what changed and why; do not combine unrelated edits silently.
- Review response: submission date, factual explanation and resulting decision.
- Next verification: confirm destination, response workflow and any unresolved separate restrictions.
An illustrative entry might say: ad rejected, personal-attributes label, copy implies knowledge of the viewer's skin concern, reviewer to assess a service-focused alternative. That is a proposed diagnostic example, not a report of a real rejection or a guarantee that revised wording will be approved.
Make the review request specific and honest
If an identified issue has been corrected, explain the correction and point to the relevant version. If you believe the decision is mistaken, explain which element was reviewed, which official rule you checked and why the material appears consistent with it.
Do not claim that a clinician has reviewed the ad unless they have. Do not attach patient histories or private images as evidence. The platform needs the campaign context, not unnecessary sensitive material.
Keep an owner for the pending investigation and record the response. Avoid a cycle of repeated appeals with no new evidence. If the restriction remains unclear, use the account's available support route and pause affected activity as appropriate while obtaining qualified advice.
Turn the incident into a reusable preflight
Once the issue is understood, add the specific check to the practice's launch process. That might mean a clearer offer approval, a current-policy check or destination review before creative is uploaded. It should not become an ever-growing list of unexplained banned words.
For the next-step experience, see aesthetic clinic websites and consultation paths. If your real problem is contact quality rather than rejection, use lead forms versus website inquiry forms.
Fyntrix's patient acquisition work can help connect these checks, but the log is yours to use independently. Respond to the actual policy issue, not an imagined list of forbidden words.